Expect the Unexpected: SGLT-2 Inhibitors in the Treatment of Type 2 Diabetes and/or Heart Failure

Cardiology. 2020;145(5):321-323. doi: 10.1159/000506731. Epub 2020 Mar 20.

Authors

Jelena P Seferovic¹, Petar M Seferovic^{2

3}

Affiliations

¹ Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia, jpseferovic@gmail.com.
² University of Belgrade Faculty of Medicine, Belgrade, Serbia.
³ Serbian Academy of Sciences and Arts, Belgrade, Serbia.

PMID: 32200379
DOI: 10.1159/000506731

No abstract available

Publication types

Comment

MeSH terms

Diabetes Mellitus, Type 2*
Dipeptidyl-Peptidase IV Inhibitors*
Heart Failure*
Humans
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors*

Substances

Dipeptidyl-Peptidase IV Inhibitors
Hypoglycemic Agents
Sodium-Glucose Transporter 2 Inhibitors